| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | tofacitinib | FAERS: 34 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 2 | Aripiprazole | FAERS: 13 | US FAERS | |
| 3 | carbidopa, levodopa drug combination | FAERS: 11 | US FAERS | |
| 4 | Methotrexate | FAERS: 5 | US FAERS | |
| 5 | Glatiramer Acetate | FAERS: 4 | US FAERS | |
| 6 | Naproxen | FAERS: 4 | US FAERS | |
| 7 | apremilast | FAERS: 4 | US FAERS | |
| 8 | Bosentan | FAERS: 3 | US FAERS | |
| 9 | Fingolimod Hydrochloride | FAERS: 3 | US FAERS | |
| 10 | Methotrexate | FAERS: 3 | US FAERS | |
| 11 | Zoledronic Acid | FAERS: 3 | US FAERS | |
| 12 | teriflunomide | FAERS: 3 | US FAERS | |
| 13 | Acitretin | FAERS: 2 | US FAERS | |
| 14 | Baclofen | FAERS: 2 | US FAERS | |
| 15 | Ceftriaxone | FAERS: 2 | US FAERS | |
| 16 | Clozapine | FAERS: 2 | US FAERS | |
| 17 | Dimethyl Fumarate | FAERS: 2 | US FAERS | |
| 18 | Docetaxel | FAERS: 2 | US FAERS | |
| 19 | Everolimus | FAERS: 2 | US FAERS | |
| 20 | Ibuprofen | FAERS: 2 | US FAERS | |
| 21 | Imatinib Mesylate | FAERS: 2 | US FAERS | |
| 22 | Levofloxacin | FAERS: 2 | US FAERS | |
| 23 | Mesalamine | FAERS: 2 | US FAERS | |
| 24 | Minocycline | FAERS: 2 | US FAERS | |
| 25 | Rivaroxaban | FAERS: 2 | US FAERS | |
| 26 | Teriparatide | FAERS: 2 | US FAERS | |
| 27 | empagliflozin | FAERS: 2 | US FAERS | |
| 28 | gadobutrol | FAERS: 2 | US FAERS | |
| 29 | 4-hydroxybutyric acid | FAERS: 1 | US FAERS | |
| 30 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 1 | US FAERS | |
| 31 | Allopurinol | FAERS: 1 | US FAERS | |
| 32 | Amoxicillin-Potassium Clavulanate Combination | FAERS: 1 | US FAERS | |
| 33 | Amoxicillin | FAERS: 1 | US FAERS | |
| 34 | Atorvastatin | FAERS: 1 | US FAERS | |
| 35 | Breo Ellipta | FAERS: 1 | US FAERS | |
| 36 | Capecitabine | FAERS: 1 | US FAERS | |
| 37 | Cefazolin | FAERS: 1 | US FAERS | |
| 38 | Dabigatran | FAERS: 1 | US FAERS | |
| 39 | Daptomycin | FAERS: 1 | US FAERS | |
| 40 | Daptomycin | FAERS: 1 | US FAERS | |
| 41 | Deferoxamine | FAERS: 1 | US FAERS | |
| 42 | Dronedarone | FAERS: 1 | US FAERS | |
| 43 | Droxidopa | FAERS: 1 | US FAERS | |
| 44 | Exenatide | FAERS: 1 | US FAERS | |
| 45 | Ezetimibe, Simvastatin Drug Combination | FAERS: 1 | US FAERS | |
| 46 | Gabapentin | FAERS: 1 | US FAERS | |
| 47 | Lamotrigine | FAERS: 1 | US FAERS | |
| 48 | Leflunomide | FAERS: 1 | US FAERS | |
| 49 | Lenalidomide | FAERS: 1 | US FAERS | |
| 50 | Linezolid | FAERS: 1 | US FAERS | |
| 51 | Lorazepam | FAERS: 1 | US FAERS | |
| 52 | Meropenem | FAERS: 1 | US FAERS | |
| 53 | Mitotane | FAERS: 1 | US FAERS | |
| 54 | Nitrofurantoin | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 55 | Norgestrel | FAERS: 1 | US FAERS | |
| 56 | Octreotide | FAERS: 1 | US FAERS | |
| 57 | Olanzapine | FAERS: 1 | US FAERS | |
| 58 | Pamidronate | FAERS: 1 | US FAERS | |
| 59 | Phenytoin | FAERS: 1 | US FAERS | |
| 60 | Piperacillin/tazobactam | FAERS: 1 | US FAERS | |
| 61 | Propranolol | FAERS: 1 | US FAERS | |
| 62 | Rosuvastatin Calcium | FAERS: 1 | US FAERS | |
| 63 | Sulfasalazine | FAERS: 1 | US FAERS | |
| 64 | Synjardy | FAERS: 1 | US FAERS | |
| 65 | Thalidomide | FAERS: 1 | US FAERS | |
| 66 | Vitamin K | FAERS: 1 | US FAERS | |
| 67 | Voriconazole | FAERS: 1 | US FAERS | |
| 68 | apixaban | FAERS: 1 | US FAERS | |
| 69 | atovaquone, proguanil drug combination | FAERS: 1 | US FAERS | |
| 70 | elagolix | FAERS: 1 | US FAERS | |
| 71 | etonogestrel | FAERS: 1 | US FAERS | |
| 72 | exemestane | FAERS: 1 | US FAERS | |
| 73 | gemcitabine | FAERS: 1 | US FAERS | |
| 74 | lanreotide | FAERS: 1 | US FAERS | |
| 75 | pirfenidone | FAERS: 1 | US FAERS | |
| 76 | pomalidomide | FAERS: 1 | US FAERS | |
| 77 | regorafenib | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.